All Vaccinology articles – Page 2
-
FeaturesEquity and the response to Covid 19 - Preparing for the next pandemic in Aotearoa New Zealand
Aotearoa New Zealand enacted an effective response to the Covid-19 pandemic. The government approach to the first few cases in March 2020 was to implement a swift ‘go hard and go early’ response. Borders were closed to non-residents, lockdowns were enforced, and infection was effectively eliminated within 76 days of ...
-
NewsBrazilian medical students increase vaccine confidence
Vaccination coverage in Brazil has declined in recent years. Medical students at the University of Pernambuco designed and delivered a low-cost, two-hour educational intervention for 25 parents and caregivers waiting for routine appointments at a Family Health Unit in Recife.
-
NewsNew immune system enhancer extends COVID-19 vaccine protection reducing need for repeated boosters
Researchers demonstrated that pairing the original COVID-19 mRNA vaccine with an adjuvant extended the duration of the vaccine’s protection in mice from a few months up to two years. The combo also showed a more pronounced response against omicron viral components than the vaccine alone.
-
NewsSurvey highlights persistent uncertainty on STI vaccines
A nationally representative survey of empaneled adults finds that while most Americans understand how STIs spread, there are significant gaps in public knowledge about which infections can be prevented through vaccination.
-
NewsScientists harness T cells to help the body fight entire viral families
Scientists have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine, protecting against life-threatening infections from Lassa virus, Junin virus, and other arenaviruses with pandemic potential.
-
NewsInfluenza virus platforms: New hope for vaccines and cancer immunotherapy
Influenza virus is now being engineered to carry foreign genes and reduce virulence, serving not only for next-generation influenza vaccines but also as delivery vectors for heterologous antigens against other infections and cancers, supported by its ability to trigger robust mucosal and systemic immune responses.
-
NewsNo refrigeration needed for killer disease vaccine
Malaria kills more than half a million people every year, but a new vaccine is showing promise as it not only offers long-lasting strong protection but also inhibits transmission of malaria by mosquitos. The vaccine is predicted to be low cost and its cold-chain independence strongly enhances its deployability.
-
NewsCommentary: Dengue viral infection and associated liver disease
A new commentary highlights the time course of serological and liver enzyme elevations in mild versus severe dengue, emphasizes early recognition of progression to acute liver failure, and reviews current vaccination and prevention strategies.
-
NewsPregnant women’s mental images are directly linked to vaccine hesitancy and uptake
When pregnant women think about vaccinations, many experience vivid mental images – such as a sick baby in hospital – that have a direct link to their opinion of the vaccine and whether they ultimately have it, new research has shown.
-
NewsNeedle-free flu vaccine aims to boost children’s immunity
A new study will explore the effects of a nasal spray flu vaccine on children’s immune systems, aiming to boost future protection and lower vaccine hesitancy rates.
-
NewsSeasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada
An interim analysis estimates that the COVID-19 vaccine for the 2025/26 season reduced the risk of illness in Canada by about half at about 9 weeks after vaccination, offering protection beyond the vaccine’s target strain.
-
NewsReview finds no direct link between aluminium adjuvanted vaccines and serious or long term health conditions
Current evidence does not support direct (causal) associations between aluminium adjuvanted vaccines and serious or long term health outcomes, including autism, diabetes and asthma, finds a review of the latest data.
-
NewsStudy finds four of the CDC’s seven measles elimination status indicators missed
After public health experts declared measles eliminated in the U.S. in 2000, the U.S. CDC established seven indicators of measles elimination status to ensure that the country remained on track. Now researchers find that the U.S. missed four of the seven criteria, with the others at risk.
-
NewsChanges in CDC communication undermine public trust in vaccines
Exposure to uncertainty-based messaging about vaccines increased perceived vaccine risks and uncertainty, reduced vaccination intentions, lowered trust in the CDC, and increased endorsement of science-denial strategies.
-
NewsYour nose is a battlefield
Scientists have discovered that FluMist can trigger an immune response directly in nasal tissue in adults. The vaccine trains immune cells in the upper nasal passages to recognize and fight influenza virus infection. This immune response stays in the upper airways and can’t be detected via blood samples.
-
NewsVaccine strategy induces broadly neutralising HIV antibodies
Researchers have developed a new vaccine strategy that has generated antibodies capable of neutralising highly divergent HIV variants. The study provides new insights into how the immune system can be guided towards a particularly protected part of the virus.
-
NewsNew study suggests seasonal flu vaccines may reduce severity of H5N1 bird flu infections
Researchers have found that seasonal influenza vaccines in routine global use may significantly reduce the risk of death from H5N1 infection. The findings that readily available tools may offer protection while the world races to develop more targeted solutions.
-
NewsNew study suggests reduced newborn hepatitis B vaccination coverage may increase infant infections
Researchers found that lower vaccination coverage among infants born to unscreened mothers was associated with a substantial increase in HBV infections.
-
NewsWhere people get their news influences their beliefs about vaccines
People who follow “new right” media outlets are more than twice as likely to be vaccine-hesitant compared to those who never engage with those outlets, a new study finds. Hesitant adults were more likely to rely on non-authoritative sources for health information.
-
NewsGlobal Virus Network statement on H5N1 vaccine developments
The new vaccine momentum reflects the growing urgency of avian influenza (H5N1) threat and reinforces the need for coordinated global preparedness.